Details for New Drug Application (NDA): 050167
✉ Email this page to a colleague
NDA 050167 describes POLYSPORIN, which is a drug marketed by Glaxosmithkline and Monarch Pharms and is included in two NDAs. Additional details are available on the POLYSPORIN profile page.
The generic ingredient in POLYSPORIN is bacitracin zinc; polymyxin b sulfate. There are twenty-seven drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the bacitracin zinc; polymyxin b sulfate profile page.
The generic ingredient in POLYSPORIN is bacitracin zinc; polymyxin b sulfate. There are twenty-seven drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the bacitracin zinc; polymyxin b sulfate profile page.
Summary for 050167
| Tradename: | POLYSPORIN |
| Applicant: | Glaxosmithkline |
| Ingredient: | bacitracin zinc; polymyxin b sulfate |
| Patents: | 0 |
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | AEROSOL;TOPICAL | Strength | 10,000 UNITS/GM;2,000,000 UNITS/GM | ||||
| Approval Date: | Mar 1, 1985 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
